Cowen Starts Seres Therapeutics (MCRB) at Outperform
Tweet
Share
E-mailGet Alerts MCRB Hot Sheet
Price: $5.11 -4.13%
Rating Summary:
9 Buy, 3 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 42
Rating Summary:
9 Buy, 3 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 42
Join SI Premium – FREE
Cowen initiated coverage on Seres Therapeutics (NASDAQ: MCRB) with an Outperform rating.
For an analyst ratings summary and ratings history on Seres Therapeutics click here. For more ratings news on Seres Therapeutics click here.
Shares of Seres Therapeutics closed at $29.92 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cantor Fitzgerald Starts Trulieve Cannabis (TRLV) at Overweight, 'Purpose-Built for a New Cannabis Regulatory Framework'
- Maxim Group Starts Rein Therapeutics (RNTX) at Buy
- H.C. Wainwright Starts Sophia Genetics SA (SOPH) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
